Consolidated Portfolio Review Corp Abb Vie Inc. Transaction History
Consolidated Portfolio Review Corp
- $448 Billion
- Q3 2024
A detailed history of Consolidated Portfolio Review Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 1,597 shares of ABBV stock, worth $263,489. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,597
Previous 2,138
25.3%
Holding current value
$263,489
Previous $367 Million
14.0%
% of portfolio
0.07%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,841Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$28.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$22.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.6 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.39 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $292B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...